The single-use bioreactors market would grow at a CAGR of 18.67% over the predicted time frame. The market is expected to increase in value from US$ 4.69 Bn in 2022 to US$ 18.43 Bn in 2030.
Key Takeaways:
- North America has accounted highest revenue share of around 31.5% in 2021.
- By end use, the CMOs and CROs segment has captured 40% revenue share in 2021.
- By usage type, the lab-scale production segment has reached 37% revenue share in 2021.
- By application, the research and development (R&D)/process development segment has held 75.5% revenue share in 2021.
- By molecule type, the vaccines segment has accounted revenue share of around 26% in 2021.
- By type of cell, the mammalian cells segment has accounted 81% market share in 2021.
- By type, stirred tank bioreactors segment has accounted 82% of the total revenue share in 2021.
- By product, the single-use bioreactor systems segment has held 80.6% revenue share in 2021
The on single-use bioreactors Market, which provides a business strategy, research & development activities, concise outline of the market valuation, valuable insights pertaining to market share, size, supply chain analysis, competitive landscape and regional proliferation of this industry.
Download Free Sample@ https://www.precedenceresearch.com/sample/2308
A recent report provides crucial insights along with application based and forecast information in the Global Single-use bioreactors Market. The report provides a comprehensive analysis of key factors that are expected to drive the growth of this market. This study also provides a detailed overview of the opportunities along with the current trends observed in the Single-use bioreactors market.
A quantitative analysis of the industry is compiled for a period of 10 years in order to assist players to grow in the market. Insights on specific revenue figures generated are also given in the report, along with projected revenue at the end of the forecast period.
Companies and Manufacturers Covered
The study covers key players operating in the market along with prime schemes and strategies implemented by each player to hold high positions in the industry. Such a tough vendor landscape provides a competitive outlook of the industry, consequently existing as a key insight. These insights were thoroughly analysed and prime business strategies and products that offer high revenue generation capacities were identified. Key players of the global Single-use bioreactors market are included as given below:
Single-use bioreactors Market Key Players
- ABEC Inc.
- Able Corporation & Biott Corporation (Japan)
- Applikon Biotechnology B.V.
- Aptus bioreactors.
- Cell culture company
- Cellexus Ltd
- Celltainer Biotech BV (Netherlands)
- CESCO Bioengineering Co., Ltd.
- Danaher Corporation
- Distek Inc. (US)
- ENDEL ENGIE
- Eppendorf AG (Germany)
- G&G Technologies Inc. (Australia)
- GE Healthcare
- Getinge AB (Sweden)
- GPC Bio
- Infors AG.
- Meissner Filtration Products Inc.
- Merck KgaA (Germany)
- New Horizon Biotechnology Inc.
- OmniBRx Biotechnologies
- Pall Corporation
- Parker-Hannifin Corporation,
- PBS Biotech Inc. (US)
- Pierre Guerin Technologies
- Sartorius Stedim Biotech (Germany)
- Satake Chemical Equipment Mfg., Ltd. (Japan)
- Solaris Biotechnology SRL
- Solida Biotech GmbH (Germany)
- Stobbe Pharma GmbH (Germany)
- Thermo Fisher Scientific (US)
Market Segments
By Product
- Single-use Bioreactor Systems
- Up to 10L
- 11-100L
- 101-500L
- 501-1500L
- Above 1500L
- Single-use Media Bags
- 2D Bags
- 3D Bags
- Others
- Single-use Filtration Assemblies
- Other Products
By Type
- Stirred-tank SUBs
- Bubble-column SUBs
- Wave-induced SUBs
- Other SUBs
By Type of Cell
- Mammalian Cells
- Yeast Cells
- Bacterial Cells
- Others
By Molecule Type
- Monoclonal Antibodies
- Vaccines
- Stem Cells
- Gene Modified Cells
- Others
By Application
- Research and Development (R&D) or Process Development
- Bioproduction
By End-Use
- CROs & CMOs
- Pharmaceutical & Biopharmaceutical Companies
- Academic & Research Institutes
By Usage Type
- Pilot-scale Production
- Lab-scale Production
- Large-scale Production
By Geography
- North America
- Europe
- Asia-Pacific
- Latin America
- Middle East & Africa (MEA)
Report Objectives
- To define, describe, and forecast the global single-use bioreactors market based on product, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, opportunities, and industry-specific challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, future prospects, and contributions to the total market
- To analyze opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments with respect to four main regions—North America, Europe, Asia Pacific and the Rest of the World (RoW)2
- To strategically profile key players and comprehensively analyze their product portfolios, market shares, and core competencies3
- To track and analyze competitive developments such as acquisitions, expansions, new product launches, and partnerships in the single-use bioreactors market
Table of Content
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. Market Dynamics Analysis and Trends
5.1. Market Dynamics
5.1.1. Market Drivers
5.1.2. Market Restraints
5.1.3. Market Opportunities
5.2. Porter’s Five Forces Analysis
5.2.1. Bargaining power of suppliers
5.2.2. Bargaining power of buyers
5.2.3. Threat of substitute
5.2.4. Threat of new entrants
5.2.5. Degree of competition
Chapter 6. Competitive Landscape
6.1.1. Company Market Share/Positioning Analysis
6.1.2. Key Strategies Adopted by Players
6.1.3. Vendor Landscape
6.1.3.1. List of Suppliers
6.1.3.2. List of Buyers
Chapter 7. Global Single-use Bioreactors Market, By Product
7.1. Single-use Bioreactors Market, by Product, 2022-2030
7.1.1. Single-use Bioreactor Systems
7.1.1.1. Market Revenue and Forecast (2017-2030)
7.1.2. Single-use Media Bags
7.1.2.1. Market Revenue and Forecast (2017-2030)
7.1.3. Single-use Filtration Assemblies
7.1.3.1. Market Revenue and Forecast (2017-2030)
7.1.4. Other Products
7.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 8. Global Single-use Bioreactors Market, By Type
8.1. Single-use Bioreactors Market, by Type, 2022-2030
8.1.1. Stirred-tank SUBs
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Bubble-column SUBs
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Wave-induced SUBs
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Other SUBs
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Single-use Bioreactors Market, By Type of Cell
9.1. Single-use Bioreactors Market, by Type of Cell, 2022-2030
9.1.1. Mammalian Cells
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Yeast Cells
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Bacterial Cells
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Others
9.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Single-use Bioreactors Market, By Molecule Type
10.1. Single-use Bioreactors Market, by Molecule Type, 2022-2030
10.1.1. Monoclonal Antibodies
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Vaccines
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Stem Cells
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Gene Modified Cells
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Others
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Single-use Bioreactors Market, By Application
11.1. Single-use Bioreactors Market, by Application, 2022-2030
11.1.1. Research and Development (R&D) or Process Development
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Bioproduction
11.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Single-use Bioreactors Market, By End-Use
12.1. Single-use Bioreactors Market, by End-Use, 2022-2030
12.1.1. CROs & CMOs
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Pharmaceutical & Biopharmaceutical Companies
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Academic & Research Institutes
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Single-use Bioreactors Market, By Usage Type
13.1. Single-use Bioreactors Market, by Usage Type, 2022-2030
13.1.1. Pilot-scale Production
13.1.1.1. Market Revenue and Forecast (2017-2030)
13.1.2. Lab-scale Production
13.1.2.1. Market Revenue and Forecast (2017-2030)
13.1.3. Large-scale Production
13.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 14. Global Single-use Bioreactors Market, Regional Estimates and Trend Forecast
14.1. North America
14.1.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.1.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.1.5. Market Revenue and Forecast, by Application (2017-2030)
14.1.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.1.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.1.8. U.S.
14.1.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.1.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.1.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.1.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.1.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.1.9. Rest of North America
14.1.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.1.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.1.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.1.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.1.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.1.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.1.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2. Europe
14.2.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2.8. UK
14.2.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2.9. Germany
14.2.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2.10. France
14.2.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.10.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.10.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.2.11. Rest of Europe
14.2.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.2.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.2.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.2.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.2.11.5. Market Revenue and Forecast, by Application (2017-2030)
14.2.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.2.11.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3. APAC
14.3.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3.8. India
14.3.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3.9. China
14.3.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3.10. Japan
14.3.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.10.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.10.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.3.11. Rest of APAC
14.3.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.3.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.3.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.3.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.3.11.5. Market Revenue and Forecast, by Application (2017-2030)
14.3.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.3.11.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4. MEA
14.4.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4.8. GCC
14.4.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4.9. North Africa
14.4.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4.10. South Africa
14.4.10.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.10.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.10.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.10.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.10.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.10.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.10.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.4.11. Rest of MEA
14.4.11.1. Market Revenue and Forecast, by Product (2017-2030)
14.4.11.2. Market Revenue and Forecast, by Type (2017-2030)
14.4.11.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.4.11.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.4.11.5. Market Revenue and Forecast, by Application (2017-2030)
14.4.11.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.4.11.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.5. Latin America
14.5.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.5.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.5.5. Market Revenue and Forecast, by Application (2017-2030)
14.5.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.5.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.5.8. Brazil
14.5.8.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.8.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.8.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.5.8.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.5.8.5. Market Revenue and Forecast, by Application (2017-2030)
14.5.8.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.5.8.7. Market Revenue and Forecast, by End-Use (2017-2030)
14.5.9. Rest of LATAM
14.5.9.1. Market Revenue and Forecast, by Product (2017-2030)
14.5.9.2. Market Revenue and Forecast, by Type (2017-2030)
14.5.9.3. Market Revenue and Forecast, by Type of Cell (2017-2030)
14.5.9.4. Market Revenue and Forecast, by Molecule Type (2017-2030)
14.5.9.5. Market Revenue and Forecast, by Application (2017-2030)
14.5.9.6. Market Revenue and Forecast, by Usage Type (2017-2030)
14.5.9.7. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 15. Company Profiles
15.1. ABEC Inc.
15.1.1. Company Overview
15.1.2. Product Offerings
15.1.3. Financial Performance
15.1.4. Recent Initiatives
15.2. Able Corporation & Biott Corporation (Japan)
15.2.1. Company Overview
15.2.2. Product Offerings
15.2.3. Financial Performance
15.2.4. Recent Initiatives
15.3. Applikon Biotechnology B.V.
15.3.1. Company Overview
15.3.2. Product Offerings
15.3.3. Financial Performance
15.3.4. Recent Initiatives
15.4. Aptus bioreactors.
15.4.1. Company Overview
15.4.2. Product Offerings
15.4.3. Financial Performance
15.4.4. Recent Initiatives
15.5 Cell culture company
15.5.1. Company Overview
15.5.2. Product Offerings
15.5.3. Financial Performance
15.5.4. Recent Initiatives
15.6. Cellexus Ltd
15.6.1. Company Overview
15.6.2. Product Offerings
15.6.3. Financial Performance
15.6.4. Recent Initiatives
15.7. Celltainer Biotech BV (Netherlands)
15.7.1. Company Overview
15.7.2. Product Offerings
15.7.3. Financial Performance
15.7.4. Recent Initiatives
15.8. CESCO Bioengineering Co., Ltd.
15.8.1. Company Overview
15.8.2. Product Offerings
15.8.3. Financial Performance
15.8.4. Recent Initiatives
15.9. Danaher Corporation
15.9.1. Company Overview
15.9.2. Product Offerings
15.9.3. Financial Performance
15.9.4. Recent Initiatives
15.10. Distek Inc. (US)
15.10.1. Company Overview
15.10.2. Product Offerings
15.10.3. Financial Performance
15.10.4. Recent Initiatives
Chapter 16. Research Methodology
16.1. Primary Research
16.2. Secondary Research
16.3. Assumptions
Chapter 17. Appendix
17.1. About Us
17.2. Glossary of Terms
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 774 402 6168
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
0 Comments